Omniflow II for Vascular Access is a Biosynthetic Vascular Prosthesis indicated when a viable AV fistula cannot be constructed. Clinical evidence shows that Omniflow II is superior to synthetic grafts.
High Primary Patency means more time to the first revision
High Secondary Patency means more time after first revision
Low infection rate means more time without complications
Ease of handling
Bio Nova International Pty Ltd | Biosynthetic Tissue Manufacturer
Bio Nova International is the leading biosynthetic tissue manufacturer in the world, specialising in collagen based medical devices.
Bio Nova is fully accredited to ISO13485 as a medical device ...